Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)

Clinical trial NCT00759135 · COMPLETED

Trial details

NCT number: NCT00759135
Sponsor: Nymox Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia (BPH)Enlarged Prostate

Start date: 2007-05-01
Primary completion: 2008-01-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.